Work

26P Capmatinib in treatment (Tx)-naive MET exon 14-mutated (METex14) advanced non-small cell lung Cancer (aNSCLC): Updated results from GEOMETRY mono-1

Year: 2022

Type: article

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2022.02.035

Authors: J. Wolf, E.B. Garon, H.J.M. Groen, D.S.W. Tan, A. Robeva, S. Le Mouhaer, M. Carbini, A. Yovine, R. Heist

Institutions: University Hospital Cologne, University of California, Los Angeles, University Medical Center Groningen, National Cancer Centre Singapore, Novartis (France), Novartis (Switzerland), Massachusetts General Hospital

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4226317762

FWCI: 1.265

Cites:

Cited by: 9

Related to: 10